Last $15.23 USD
Change Today +0.205 / 1.36%
Volume 359.3K
NKTR On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - NEKTAR THERAPEUTICS (NKTR)

Nektar Therapeutics to Report Q3, 2014 on Nov 06, 2014
CapIQ 11/06/2014 10:00 PM ET
Nektar Therapeutics to Report Q2, 2014 on Jul 31, 2014
CapIQ 11/06/2014 10:00 PM ET
Nektar Therapeutics to Report Q1, 2014 on May 07, 2014
CapIQ 11/06/2014 10:00 PM ET

2013 revenues at Nektar Therapeutics totaled $148.9M USD, while annual losses equaled $1.40 per share.

Quarterly Earnings & Estimates - NEKTAR THERAPEUTICS (NKTR)

Actuals vs. Estimates for NEKTAR THERAPEUTICS NKTR

Nektar Therapeutics's Quarterly Earnings

Nektar Therapeutics reported 2nd quarter 2014 losses of $0.26 per share on 08/2/2014.

Annual Earnings & Estimates - NEKTAR THERAPEUTICS (NKTR)

Actuals vs. Estimates for NEKTAR THERAPEUTICS NKTR

Nektar Therapeutics's Annual Earnings

Nektar Therapeutics reported annual 2013 losses of $1.40 per share on 02/28/2014.

Quarterly Revenues - NEKTAR THERAPEUTICS (NKTR)

Actuals vs. Estimates for NEKTAR THERAPEUTICS NKTR

Nektar Therapeutics's Quarterly Revenues

Nektar Therapeutics had 2nd quarter 2014 revenues of $28.5M USD. This bettered the $19.8M USD consensus of the 8 analysts covering the company. This was -15.8% below the prior year's 2nd quarter results.

Annual Revenues - NEKTAR THERAPEUTICS (NKTR)

Actuals vs. Estimates for NEKTAR THERAPEUTICS NKTR

Nektar Therapeutics's Annual Revenues

Nektar Therapeutics had revenues for the full year 2013 of $148.9M USD. This was 83.4% above the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NKTR:US $15.23 USD +0.205

NKTR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Depomed Inc $15.69 USD +0.145
Emergent Biosolutions Inc $27.93 USD +0.29
Ironwood Pharmaceuticals Inc $14.95 USD +0.38
Synergy Health PLC 2,031 GBp -45.00
Theravance Inc $15.03 USD +0.48
View Industry Companies
 

Industry Analysis

NKTR

Industry Average

Valuation NKTR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 9.1x
Price/Book 41.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 7.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEKTAR THERAPEUTICS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.